Kuliah Neuropathic Pain-1
Kuliah Neuropathic Pain-1
Kuliah Neuropathic Pain-1
Susi Aulina
Makassar September 16th, 2006
INTRODUCTION
NEUROPATHIC PAIN (Ne P) can be defined as :
INTRODUCTION
contd
CLINICAL FEATURE
(FIELDS 1987)
CLINICAL FEATURE
contd
CLINICAL FEATURE
contd
CLINICAL FEATURE
Neuropathic Pain
Stimulus-evoked pain
Stimulus-independent pain
Continous
non-noxious
stimulus
Paroxysmal
Mechanical
Allodinia
Dynamic
Static
Therma
Allodinia
Noxious
stimulus
Mechanical
Hyperalgesia
Dynamic
Thermal
Hyperalgesia
Static
Noxious stimulus
Hyperalgesia
Respons
Allodinia
Stimulus Intensity
Martin, 1998.
Normal
Alodinia
Nerve injury triggers central reorganization on dorsal horn
of spinal cord
normal
A
C
after injury
Woolf, 1994.
Midline
Superficial
Hyperalgesia
Mechanism : peripheral sensitization
Vasodilatasi
Hiperalgesia
6
5
Edema
4
3
2
1
Hyperalgesia
Continuous
noxious stimuli
CLINICAL FEATURE
contd
CLINICAL FEATURE
contd
NoP :
is mediated by activation of pain receptors
by algogenic substances (histamine, bradykinin,
substance P, etc)
can be further classified as :
Somatic (localized aching or throbbing)
Or visceral (colicky) pain
Gabapentin
ETIOLOGY OF
NEUROPATHIC
is :
NeP
PAIN
initiated or caused by :
MECHANISMS of NEUROPATHIC
PAIN
PERIPHERAL MECHANISMS
Sensitization of primary afferent
nociceptor terminals :
Ectopic activity
Alteration of neurotransmitter
Coupling between the sympathetic and
sensory nervous system
CENTRAL MECHANISMS
Anatomical reorganization
Ectopic activity
Loss of segmental inhibition
Sensitization of spinal neurons
TREATMENT of NEUROPATHIC
PAIN
Regardless of the cause, Ne P :
Affects multiple aspects of patients life
TREATMENT of Ne P
contd
TREATMENT of Ne P
contd
PHARMACOLOGICAL TREATMENT
Woolf and Mannion (1999) have suggested :
targeting treatment based on the mechanism
(s) involved
at present : treatment mainly depends on
empirical symptomatic treatment with a
multitude of medications that affect neuronal
function
PHARMACOLOGICAL TREATMENT
contd
Lesi
Otak
TCA
Th/
NE/5HT
Reseptor
opioid
Medulla
Spinalis
Sensitisasi perifer/ ion Na
Th/
GABAPENTIN
Karbamazepin
Okskarbazepin
FENITOIN
Meksiletin
Lidokain, dll
Tramadol
Opioid
dll
Sensitisasi
sentral
(NMDA,
Calcium)
Th/
GABAPENTIN
Okskarbazepin
Lamotrigin
Ketamin
Dextromethorphan
NE/SHT
Reseptor
Opoid
TCA
Tramadol
Opioid
DLL
Medula
Spinalis
Beydoun, 2002
Modifikasi Meliala, 2003
Medula
Spinalis
GABAPENTIN
KARBAMAZEPIN
OKSKARBAZEPIN
Th/
FENITOIN
MEKSILETIN
LIDOKAIN
DLL
Beydoun, 2002
Modifikasi Meliala, 2003
Medula
Spinalis
Sensitisasi perifer
ion Na
Beydoun, 2002
Modifikasi Meliala, 2003
Sensitisasi
Sentral
(NMDA,
Calcium)
Th/
GABAPENTIN
Okskarbazepin
Lamotrigin
Ketamin
Dextrometorphan
Metorphan
DLL
PAIN ASSESSMENT
Visual Analog Scale (VAS)
PSYCHOLOGICAL TREATMENT
The goal : to modulate pain at spinal and
supraspinal level
The first step is to decrease or to
eliminate depression
The methods for example : cognitive
behavioural therapy (CBT) and hypnosis
PSYCHOLOGICAL TREATMENT
contd
CBT :
are multimodal treatment packages
combine education about pain and training
in a variety of cognitive and behavioural
coping skills
PHYSICAL TREATMENT
Pain modulation : thermal modalities,
Trans cutaneous
Electrical Nerve
stimulation
(TENS),
acupuncture
Muscle exercises
Vocational rehabilitation
INTERVENTIONAL TREATMENTS
These procedures include :
nerve blocks (somatic/sympathetic blocks)
a tunneled epidural catheter for long term
temporary treatment
neurostimulation (typically with an implantable
spinal cord stimulator)
an intrathecal pump.
SUMMARY :
STRATEGIES FOR Ne P MANAGEMENT
Most invasive
Less invasive
Psychologic/physical therapy
Topical therapy
Oral therapy
Injection therapy
Interventional therapy